vs
EyePoint, Inc.（EYPT）与RAPID MICRO BIOSYSTEMS, INC.（RPID）财务数据对比。点击上方公司名可切换其他公司
RAPID MICRO BIOSYSTEMS, INC.的季度营收约是EyePoint, Inc.的18.2倍（$11.3M vs $619.0K）。RAPID MICRO BIOSYSTEMS, INC.净利率更高（-110.8% vs -10922.3%，领先10811.5%）。RAPID MICRO BIOSYSTEMS, INC.同比增速更快（37.3% vs -94.7%）。RAPID MICRO BIOSYSTEMS, INC.自由现金流更多（$-3.3M vs $-66.0M）。过去两年RAPID MICRO BIOSYSTEMS, INC.的营收复合增速更高（41.8% vs -77.0%）
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
RAPID MICRO BIOSYSTEMS, INC. 是生命科学领域的技术企业，专注于为生物制药厂商、合同研发生产机构等客户提供自动化微生物检测及质控解决方案，可大幅缩短检测周期、提升检测精度，业务覆盖北美、欧洲、亚太等全球核心市场。
EYPT vs RPID — 直观对比
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $619.0K | $11.3M |
| 净利润 | $-67.6M | $-12.5M |
| 毛利率 | — | — |
| 营业利润率 | -11364.3% | -108.2% |
| 净利率 | -10922.3% | -110.8% |
| 营收同比 | -94.7% | 37.3% |
| 净利润同比 | -63.3% | -29.3% |
| 每股收益（稀释后） | $-0.82 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $619.0K | $11.3M | ||
| Q3 25 | $966.0K | $7.8M | ||
| Q2 25 | $5.3M | $7.3M | ||
| Q1 25 | $24.5M | $7.2M | ||
| Q4 24 | $11.6M | $8.2M | ||
| Q3 24 | $10.5M | $7.6M | ||
| Q2 24 | $9.5M | $6.6M | ||
| Q1 24 | $11.7M | $5.6M |
| Q4 25 | $-67.6M | $-12.5M | ||
| Q3 25 | $-59.7M | $-11.5M | ||
| Q2 25 | $-59.4M | $-11.9M | ||
| Q1 25 | $-45.2M | $-11.3M | ||
| Q4 24 | $-41.4M | $-9.7M | ||
| Q3 24 | $-29.4M | $-11.3M | ||
| Q2 24 | $-30.8M | $-12.6M | ||
| Q1 24 | $-29.3M | $-13.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 93.0% | — | ||
| Q2 24 | 85.2% | — | ||
| Q1 24 | 93.5% | — |
| Q4 25 | -11364.3% | -108.2% | ||
| Q3 25 | -6420.8% | -145.1% | ||
| Q2 25 | -1166.8% | -167.3% | ||
| Q1 25 | -199.7% | -161.8% | ||
| Q4 24 | -390.4% | -124.5% | ||
| Q3 24 | -311.2% | -158.3% | ||
| Q2 24 | -364.5% | -202.1% | ||
| Q1 24 | -285.2% | -254.4% |
| Q4 25 | -10922.3% | -110.8% | ||
| Q3 25 | -6183.4% | -146.8% | ||
| Q2 25 | -1114.3% | -163.3% | ||
| Q1 25 | -184.8% | -156.3% | ||
| Q4 24 | -357.3% | -117.6% | ||
| Q3 24 | -279.0% | -148.9% | ||
| Q2 24 | -325.3% | -190.1% | ||
| Q1 24 | -250.6% | -237.4% |
| Q4 25 | $-0.82 | $-0.26 | ||
| Q3 25 | $-0.85 | $-0.26 | ||
| Q2 25 | $-0.85 | $-0.27 | ||
| Q1 25 | $-0.65 | $-0.26 | ||
| Q4 24 | $-0.65 | $-0.22 | ||
| Q3 24 | $-0.54 | $-0.26 | ||
| Q2 24 | $-0.58 | $-0.29 | ||
| Q1 24 | $-0.55 | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.1M | $20.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $306.1M | $33.2M |
| 总资产 | $364.0M | $74.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $306.1M | $20.0M | ||
| Q3 25 | $204.0M | $18.9M | ||
| Q2 25 | $255.7M | $18.3M | ||
| Q1 25 | $318.2M | $18.9M | ||
| Q4 24 | $370.9M | $16.9M | ||
| Q3 24 | $253.8M | $22.0M | ||
| Q2 24 | $280.2M | $37.1M | ||
| Q1 24 | $299.3M | $22.4M |
| Q4 25 | $306.1M | $33.2M | ||
| Q3 25 | $200.2M | $44.3M | ||
| Q2 25 | $246.0M | $54.5M | ||
| Q1 25 | $298.4M | $65.5M | ||
| Q4 24 | $336.5M | $75.4M | ||
| Q3 24 | $218.7M | $84.4M | ||
| Q2 24 | $228.3M | $94.6M | ||
| Q1 24 | $249.9M | $105.9M |
| Q4 25 | $364.0M | $74.9M | ||
| Q3 25 | $251.7M | $84.4M | ||
| Q2 25 | $301.1M | $75.6M | ||
| Q1 25 | $362.6M | $85.4M | ||
| Q4 24 | $418.5M | $98.2M | ||
| Q3 24 | $300.9M | $105.8M | ||
| Q2 24 | $324.2M | $117.1M | ||
| Q1 24 | $329.2M | $127.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-65.0M | $-3.2M |
| 自由现金流经营现金流 - 资本支出 | $-66.0M | $-3.3M |
| 自由现金流率自由现金流/营收 | -10667.7% | -29.6% |
| 资本支出强度资本支出/营收 | 159.3% | 0.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-243.4M | $-31.9M |
8季度趋势，按日历期对齐
| Q4 25 | $-65.0M | $-3.2M | ||
| Q3 25 | $-59.4M | $-9.1M | ||
| Q2 25 | $-62.6M | $-9.7M | ||
| Q1 25 | $-53.1M | $-9.1M | ||
| Q4 24 | $-35.8M | $-9.9M | ||
| Q3 24 | $-39.0M | $-8.6M | ||
| Q2 24 | $-20.2M | $-10.1M | ||
| Q1 24 | $-31.2M | $-15.5M |
| Q4 25 | $-66.0M | $-3.3M | ||
| Q3 25 | $-60.2M | $-9.1M | ||
| Q2 25 | $-63.8M | $-10.1M | ||
| Q1 25 | $-53.4M | $-9.4M | ||
| Q4 24 | $-36.2M | $-10.0M | ||
| Q3 24 | $-40.6M | $-8.8M | ||
| Q2 24 | $-21.1M | $-10.6M | ||
| Q1 24 | $-32.4M | $-16.1M |
| Q4 25 | -10667.7% | -29.6% | ||
| Q3 25 | -6226.9% | -116.4% | ||
| Q2 25 | -1196.5% | -138.6% | ||
| Q1 25 | -218.4% | -130.2% | ||
| Q4 24 | -312.7% | -121.8% | ||
| Q3 24 | -385.8% | -116.0% | ||
| Q2 24 | -222.4% | -159.8% | ||
| Q1 24 | -277.0% | -287.1% |
| Q4 25 | 159.3% | 0.8% | ||
| Q3 25 | 82.6% | 0.9% | ||
| Q2 25 | 22.9% | 5.0% | ||
| Q1 25 | 1.1% | 4.4% | ||
| Q4 24 | 3.3% | 1.2% | ||
| Q3 24 | 15.0% | 2.9% | ||
| Q2 24 | 9.5% | 6.9% | ||
| Q1 24 | 10.2% | 10.4% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EYPT
暂无分部数据
RPID
| Products | $9.3M | 83% |
| Services | $2.0M | 17% |
